Gene: GOLGA6L9
Official Full Name: golgin A6 family like 9provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17347 | GOLGA6L9 Knockout cell line (HeLa) | Human | GOLGA6L9 | 1:3~1:6 | Negative | Online Inquiry |
KO17348 | GOLGA6L9 Knockout cell line (HCT 116) | Human | GOLGA6L9 | 1:2~1:4 | Negative | Online Inquiry |
KO17349 | GOLGA6L9 Knockout cell line (A549) | Human | GOLGA6L9 | 1:3~1:4 | Negative | Online Inquiry |
GOLGA6L9 gene knockout cell lines are genetically modified cell lines in which the GOLGA6L9 gene has been selectively inactivated. This product enables researchers to investigate the specific functions and biological pathways associated with the GOLGA6L9 gene, which is known to be involved in various cellular processes, including membrane trafficking and Golgi apparatus function. By providing a robust model for gene function analysis, these knockout cell lines facilitate a deeper understanding of both normal cellular physiology and the pathological processes that may arise from dysregulation of this gene.
The key mechanisms behind the function of GOLGA6L9 involve its role in the Golgi complex, where it participates in the transport and modification of proteins. Knocking out the GOLGA6L9 gene allows scientists to observe phenotypic changes and alterations in protein localization, thereby elucidating its functional contribution to intracellular dynamics. This provides critical insights into potential implications in diseases where protein trafficking is disrupted, including cancer and neurodegenerative disorders.
In research and clinical settings, GOLGA6L9 knockout cell lines are invaluable for genetic and pharmacological studies, offering a platform for high-throughput screening and target validation in drug discovery. Their application extends to elucidating molecular mechanisms, studying gene interactions, and assessing the effects of potential therapeutic agents in a controlled environment.
What sets our GOLGA6L9 gene knockout cell lines apart from other gene knockout models is the advanced precision with which our lines are curated, ensuring high specificity and reproducibility in experimental results. Additionally, our knockout lines are developed using state-of-the-art genome editing technologies, ensuring consistency and reliability.
Investing in GOLGA6L9 gene knockout cell lines empowers researchers and clinicians alike by providing a powerful tool for advancing understanding of gene function and therapeutic development. They represent a synthesis of innovative genetic engineering and biological insight, tailored to meet the evolving needs of the scientific community.
Our company prides itself on its expertise in genetic engineering and commitment to providing high-quality biological products that support cutting-edge research and foster scientific innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.